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Received April 21, 2011; accepted August 15, 2011AbstractBackground: Intrapartum administration of antibiotics lowers the risk of neonatal group B streptococcus (GBS) infection based on recommended
guidelines (a risk-based approach and a culture-based screening approach). However, many pregnant women do not undergo culture-based
screening, nor treatment with prophylactic antibiotics after a GBS risk-based approach. Therefore, the value of GBS detection in asymptom-
atic low-risk pregnant women is controversial.
Methods: A cohort study of 354 asymptomatic pregnant women at more than 37 weeks’ gestation who were planning to undergo vaginal
delivery, and 118 neonates (107 paired samples of both mother and newborn), was conducted to evaluate the GBS colonization rate of these
pregnant women and the subsequent vertical transmission rate, using a culture method.
Results: The positive rate for GBS culture was 6.2% (22/354). Among 107 paired samples, six maternal samples and one neonatal sample were
positive for GBS culture, with an estimated vertical transmission rate of 16.7% (1/6).
Conclusion: Although the positive rate of GBS culture was lower in asymptomatic low-risk pregnant women, the possibility of vertical
transmission might be high. This finding is worthy of further investigation.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Streptococcus agalactiae, known as group B streptococcus
(GBS), is the leading cause of neonatalmorbidity andmortality.1
The gastrointestinal tract, especially the rectum, is considered
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doi:10.1016/j.jcma.2011.10.011transmission from the colonized mother to the newborn is the
main route of infection, including ascending intra-uterine and
intrapartum infection, especially during vaginal deliveries.4
Intrapartum administration of antibiotics has lowered the
risk of neonatal GBS infection, especially early-onset diseases,
and significantly continued the improvement of prenatal out-
comes.5e7 Therefore, the Centers for Disease Control and
Prevention (CDC) issued recommendations for intrapartum
prophylaxis to prevent perinatal GBS in 2010, as did the
American College of Obstetricians and Gynecologists, the
American Academy of Pediatrics, the American College of
Nurse-Midwives, the American Academy of Family Physicians,
and the American Society for Microbiology.8hinese Medical Association. All rights reserved.
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methods: a risk-based approach and a culture-based screening
approach.9 The risk-based approach recommended that
women who have obstetric risk factors, including delivery at
<37 weeks’ gestation, duration of membrane rupture >18
hours, intrapartum temperature >100.4F (>38.0C), or
intrapartum nucleic acid amplification tests positive for GBS,
should receive screening and be administered intrapartum
antibiotics based on the culture result.8 The culture-based
screening approach recommends screening of all pregnant
women for vaginal and rectal GBS colonization at between 35
and 37 weeks of gestation. Colonized women will be admin-
istered intrapartum antibiotics at the time of labor.
Although few reports have retrospectively revealed the
incidence of neonatal GBS infection in Taiwan,10e16 nearly all
studies reported on the pediatric population. In addition,
pregnant women with spontaneous vaginal delivery at term
(>37 gestational weeks) within 18 hours after rupture of
membrane (a low-risk population) might not fit the recom-
mended guideline based either on risk or on culture. Actually,
the intrapartum risk factors applied to circumstances in which
screening results were not available at the time of labor and
delivery. To clarify the GBS colonization and subsequent effect
on newborns on these pregnant women in a low-risk pop-
ulation, the current study was conducted to estimate the GBS
colonization rate of these women and calculate the subsequent
effect on their newborns in a tertiary hospital in Taiwan.
2. Methods2.1. PatientsBetween September 2005 and November 2006, 472
samples, including 354 maternal and 109 neonatal samples
(including two twins) were collected. Maternal samples were
collected from the vagina before preparing for vaginal delivery.
Vaginal delivery should occur in women with a “term preg-
nancy” (i.e., at more than 37 weeks of gestation). Neonatal
samples were collected from the oral cavity immediately after
vaginal birth. The study was designed with two groups; one
was a screening-based method group (only maternal samples
obtained) and the other was the vertical transmission screening
group (both maternal and neonatal samples obtained).
In the vertical transmission screening group, only 107 pairs
were analyzed, including 107 maternal and 109 neonatal
samples, because some paired samples and some maternal
samples without a neonatal sample were excluded. The
reasons for exclusion were: (1) samples collected after rupture
of the membrane; (2) mothers were treated with prophylactic
antibiotics; or (3) cesarean section was performed for obstetric
reasons. The hospital’s ethics committee approved the study,
and informed consent was obtained from all patients.2.2. GBS culture methodsA cotton swab was taken from the women’s upper vagina
during the pelvic examination using a speculum, and a neonatalsample was taken from the secretion of the oral cavity. Then the
cotton swabs were sealed and transported to a dedicated labo-
ratory for GBS cultures. The swab for the GBS culture was
inoculated onto trypticase soy agar containing 5% sheep blood
and incubated with 5% CO2 for 48 hours at 35
C.17,18 Species
identification of b-hemolytic colonies was performed by
agglutination with a streptococcal grouping kit (Prolex Strep-
tococcal Grouping Latex Kit; Pro-Lab Diagnostics, Richmond
Hill, Ontario, Canada).18 The procedures were performed
according to the manufacturer’s instructions. The final result of
GBS infection was reported by the performing specialist.
3. Results
The mean age of the pregnant women was 28  5 years,
and the mean gestational age was 38  1 weeks. Twenty-two
of the 354 maternal vaginal samples were positive for GBS
culture, with an estimated colonization rate of 6.2% (22/354).
Among the vertical transmission screening group, only 107
paired samples (73.3%) were obtained, including 107 maternal
samples and 109 neonatal samples (two twins). Among these
paired samples, six maternal samples and one neonatal sample
were positive for GBS culture, with an estimated vertical
transmission rate of 16.7% (1/6) (Fig. 1). The neonate was
found to have positive GBS culture, but was asymptomatic and
was not treated with antibiotics. No newborns were diagnosed
as having either early-onset (within 7 days) or late-onset GBS
infection during the follow-up of 6 months.
4. Discussion
Group B streptococcal infection is the main cause of
neonatal morbidity and mortality. The mortality of reported
neonatal cases reached nearly 50% in the 1990s.19 The prev-
alence of maternal colonization varied from 10% to 30%,
depending on the regions of the world.8 Reports from Taiwan
showed prevalence ranging from 4% to 21%, depending on the
culture sites.12,14e16 Although the formal announcement and
routine clinical suggestion of the use of an intrapartum
screening policy and intrapartum antibiotic prophylaxis are
still under detabte,20 competing strategies (risk-based vs.
culture-based) for identifying chemoprophylaxis candidates
have posed a challenge to implementation of antibiotic
prophylaxis.21 In a risk-based strategy as an alternative to
culture-based screening approaches, prematurity (<37 weeks
of gestation), intrapartum fever [>100.4F (>38.0C)] and
longer than 18 hours of ruptured membranes have been used as
clinical indications for intrapartum antibiotic prophylaxis.21
In this study, the estimated prevalence of maternal coloni-
zation was only 6.21%, which was significantly lower than in
other reports (ranging from 10e30%).8,12e16,22,23 The reasons
are unclear, but contributory factors might include the specimen
collection and culture medium. Some reports show different
positive culture rates in the different culture media,2,24,25 and in
the different areas of specimen collection.26e28
This study addressed the important issue of GBS coloniza-
tion rates between mothers (6.21%) and their offspring (vertical
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Fig. 1. Flow chart showing assignment and results of the study subjects.
27M.-J. Yang et al. / Journal of the Chinese Medical Association 75 (2012) 25e28transmission rate: 16.7%). The one infant with a positive GBS
culture fortunately did not suffer from either early-onset or
late-onset disease during the study period; however, the
consequences of GBS infection in this newborn should not be
overlooked, because the occurrence rate of an early onset of
GBS disease in offspring in Taiwan ranged from 0.11 to 1.8 per
1000 live births, which contributed to 13e14% mortality
rates.10,15 Furthermore, up to three-quarters of pregnant women
(72.7%) with positive GBS culture did not have a paired
neonatal sample. That is to say, the data presented here evalu-
ated only a relatively small study population. Finally, the
majority of women enrolled into the current study had finished
their delivery within 12 hours (data not shown) and the interval
between rupture of the membrane and fetus delivery was less
than 12 hours in the vertical transmission screening group.
Recent studies in the USA and Europe revealed that
universal screening of pregnant women at 35e37 weeks’
gestation can reduce early-onset GBS disease in infants, but
not late-onset disease.29,30 In addition, even after screening,
more than 60% of the term infants with GBS disease were
born to women who had tested negative for GBS before
delivery.1 A recent review found that up to 6% of GBS carriers
remained undetected in antenatal cultures.2,31 Therefore,
intrapartum antibiotic prophylaxis could be an alternative,
although concerns about allergy or resistance to antibiotics for
GBS were present.32 A recent study from France supported the
current policy of GBS maternal prophylaxis, since it is notassociated with an excessive risk of pathogen resistance.33
Kaambwa et al tried to determine the cost-effectiveness of
alternative screening and prevention strategies, including rapid
intrapartum testing, for the prevention of early-onset neonatal
GBS infection in the UK.34 The authors found that the most
cost-effective strategy was the provision of routine intrapartum
antibiotic prophylaxis to all women without prior screening,
but they also agreed that this was unlikely to be acceptable,
given the broader concerns related to antibiotic use.34 A 2009
Cochrane review critiqued the effectiveness of intrapartum
antibiotic prophylaxis to reduce early-onset neonatal GBS
infection.35
Based on the potential risk of vertical transmission of GBS,
routine intrapartum antibiotic prophylaxis might be more
feasible. The discrepancy between the low prevalence of
maternal GBS infection in low-risk asymptomatic women and
the high vertical transmission rate is still unresolved. Large
sample sizes and expanded eligibility criteria will be needed
to clarify the limitations. Unfortunately, the opportunity to
conduct such trials has likely been lost, as practice guidelines
(albeit without good evidence) have been introduced in many
jurisdictions, as mentioned by Ohlsson and Shah in 2009.35
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